Silibinin regulated phosphorylated EGFR expression by binding to its receptor and then inhibited downstream targets and JAK2/STAT5 and PI3K/AKT signaling pathways, leading to a reduction in cancer rate.114,115. Here, AKT1 is linked to cancer.